BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10668407)

  • 1. Thyroid hormone receptor, v-ErbA, and chromatin.
    Wolffe AP; Collingwood TN; Li Q; Yee J; Urnov F; Shi YB
    Vitam Horm; 2000; 58():449-92. PubMed ID: 10668407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of N-CoR and histone deacetylase 3 by the oncoprotein v-erbA yields a chromatin infrastructure-dependent transcriptional repression pathway.
    Urnov FD; Yee J; Sachs L; Collingwood TN; Bauer A; Beug H; Shi YB; Wolffe AP
    EMBO J; 2000 Aug; 19(15):4074-90. PubMed ID: 10921888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirements for repression of retinoid X receptor by the oncoprotein P75gag-v-erbA and the thyroid hormone receptors.
    Wahlström GM; Vennström B
    Mol Endocrinol; 1998 May; 12(5):645-53. PubMed ID: 9605927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The v-ErbA oncoprotein quenches the activity of an erythroid-specific enhancer.
    Braliou GG; Ciana P; Klaassen W; Gandrillon O; Stunnenberg HG
    Oncogene; 2001 Feb; 20(7):775-87. PubMed ID: 11314012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo.
    Ciana P; Braliou GG; Demay FG; von Lindern M; Barettino D; Beug H; Stunnenberg HG
    EMBO J; 1998 Dec; 17(24):7382-94. PubMed ID: 9857194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A choice between transcriptional enhancement and repression by the v-erbA oncoprotein governed by one nucleotide in a thyroid hormone responsive half site.
    Andersson ML; Vennström B
    Oncogene; 2000 Jul; 19(32):3563-9. PubMed ID: 10951561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive transactivation by the thyroid hormone receptor and a novel pattern of activity of its oncogenic homolog v-ErbA in Xenopus oocytes.
    Nagl SB; Nelson CC; Romaniuk PJ; Allison LA
    Mol Endocrinol; 1995 Nov; 9(11):1522-32. PubMed ID: 8584030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of DNA binding sites for the V-erbA oncoprotein, the viral homolog to thyroid hormone receptor alpha.
    Harbers M; Wahlström GM; Vennström B
    J Steroid Biochem Mol Biol; 1998 Nov; 67(3):181-91. PubMed ID: 9879977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The oncoprotein P75gag-v-erbA represses thyroid hormone induced transcription only via response elements containing palindromic half-sites.
    Wahlström GM; Harbers M; Vennström B
    Oncogene; 1996 Aug; 13(4):843-52. PubMed ID: 8761306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid hormone receptor/and v-erbA. A single amino acid difference in the C-terminal region influences dominant negative activity and receptor dimer formation.
    Selmi S; Samuels HH
    J Biol Chem; 1991 Jun; 266(18):11589-93. PubMed ID: 1675637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of transformation by v-ErbA: substitution for steroid hormone receptor function in self renewal induction.
    Bauer A; Ulrich E; Andersson M; Beug H; von Lindern M
    Oncogene; 1997 Aug; 15(6):701-15. PubMed ID: 9264411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The thyroid hormone receptor functions as a ligand-operated developmental switch between proliferation and differentiation of erythroid progenitors.
    Bauer A; Mikulits W; Lagger G; Stengl G; Brosch G; Beug H
    EMBO J; 1998 Aug; 17(15):4291-303. PubMed ID: 9687498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer promoted by the oncoprotein v-ErbA may be due to subcellular mislocalization of nuclear receptors.
    Bonamy GM; Guiochon-Mantel A; Allison LA
    Mol Endocrinol; 2005 May; 19(5):1213-30. PubMed ID: 15650025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional activation by thyroid hormone receptor-beta involves chromatin remodeling, histone acetylation, and synergistic stimulation by p300 and steroid receptor coactivators.
    Lee KC; Li J; Cole PA; Wong J; Kraus WL
    Mol Endocrinol; 2003 May; 17(5):908-22. PubMed ID: 12586842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of Chromatin Structure by the Thyroid Hormone Receptor.
    Li Q; Sachs L; Shi YB; Wolffe AP
    Trends Endocrinol Metab; 1999 May; 10(4):157-164. PubMed ID: 10322411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-erbA and v-erbA modulate growth and gene expression of a mouse glial precursor cell line.
    Iglesias T; Llanos S; López-Barahona M; Pérez-Aranda A; Rodríguez-Peña A; Bernal J; Höhne A; Seliger B; Muñoz A
    Cell Growth Differ; 1994 Jul; 5(7):697-704. PubMed ID: 7947384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mechanism of action for v-ErbA: abrogation of the inactivation of transcription factor AP-1 by retinoic acid and thyroid hormone receptors.
    Desbois C; Aubert D; Legrand C; Pain B; Samarut J
    Cell; 1991 Nov; 67(4):731-40. PubMed ID: 1682056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo repression of an erythroid-specific gene by distinct corepressor complexes.
    Rietveld LE; Caldenhoven E; Stunnenberg HG
    EMBO J; 2002 Mar; 21(6):1389-97. PubMed ID: 11889044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct requirements for chromatin assembly in transcriptional repression by thyroid hormone receptor and histone deacetylase.
    Wong J; Patterton D; Imhof A; Guschin D; Shi YB; Wolffe AP
    EMBO J; 1998 Jan; 17(2):520-34. PubMed ID: 9430643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a domain required for oncogenic activity and transcriptional suppression by v-erbA and thyroid-hormone receptor alpha.
    Damm K; Evans RM
    Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10668-72. PubMed ID: 7902566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.